HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Nakaraang pagsara
$15.91
Sakop ng araw
$14.70 - $15.61
Sakop ng taon
$6.56 - $16.48
Market cap
1.97B USD
Average na Volume
1.92M
P/E ratio
45.32
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 73.47M | 8.41% |
Gastos sa pagpapatakbo | 35.22M | -29.11% |
Net na kita | 31.55M | 119.87% |
Net profit margin | 42.95 | 102.88% |
Kita sa bawat share | 0.23 | 130.00% |
EBITDA | 34.61M | 107.98% |
Aktuwal na % ng binabayarang buwis | 1.29% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 351.51M | 0.94% |
Kabuuang asset | 527.53M | -3.97% |
Kabuuang sagutin | 161.76M | 0.25% |
Kabuuang equity | 365.77M | — |
Natitirang share | 131.84M | — |
Presyo para makapag-book | 5.74 | — |
Return on assets | 14.44% | — |
Return on capital | 17.27% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 31.55M | 119.87% |
Cash mula sa mga operasyon | 44.45M | 161.02% |
Cash mula sa pag-invest | -13.77M | -30.27% |
Cash mula sa financing | -10.49M | -285.38% |
Net change in cash | 20.19M | 440.48% |
Malayang cash flow | 33.12M | 341.23% |
Tungkol
Itinatag
2012
Headquarters
Website
Mga Empleyado
130
